STOCKHOLM, SWEDEN, February 18 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Promimic has published positive results showing a reduction of bacterial growth on the company’s implant surface HAnano Surface. The results are published in the Journal of Functional Biomaterials.
Promimic has previously seen an effect on reduced adhesion of bacteria on HAnano Surface, but the recent results also show a reduction of bacterial growth. The results indicate that the effect is bacteriostatic (hinders growth) and not bactericide (germicidal), which can decrease the risk of bacterial resistance.
The results are based on in vitro tests on gram-positive and gram-negative bacteria on HAnano Surface, showing a reduction between…